Research map: Ruxolitinib combined with corticosteroids for the successful treatment of kawasaki disease-associated macrophage activation syndrome: a case report

Back to the article

Papers in this map

  1. HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis · Jan‐Inge Henter · 2006 · 5456 citations · Cited by this paper
  2. Clinical features and nonoperative strategy for first-time infected urachal cysts in infants · 2026 · Related
  3. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association · Brian W. McCrindle · 2017 · 3818 citations · Cited by this paper
  4. Sex-stratified trends in hypoplastic left heart syndrome-related mortality among children and young adults in the United States, 1999–2024: a pre- and post-COVID-19 analysis · 2026 · Related
  5. Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults · Melissa Hines · 2021 · 140 citations · Cited by this paper
  6. Risk factors and a predictive model for delayed extubation in children undergoing primary repair of tetralogy of Fallot: a retrospective cohort study with rigorous methodological validation · 2026 · Related
  7. A study of ruxolitinib response–based stratified treatment for pediatric hemophagocytic lymphohistiocytosis · Qing Zhang · 2022 · 126 citations · Cited by this paper
  8. Correlation analysis of cyclosporine A trough concentration with hematological and biochemical parameters: a retrospective study in pediatric aplastic anemia · 2026 · Related
  9. Medium-size-vessel vasculitis · Michael J. Dillon · 2009 · 121 citations · Cited by this paper
  10. Artificial intelligence in pediatric arrhythmias: current landscape, unique challenges, and translational perspectives · 2026 · Related
  11. Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial · Masaaki Mori · 2018 · 82 citations · Cited by this paper
  12. KLF1 mutation-associated congenital dyserythropoietic anemia type IV: a case report and literature review · 2026 · Related
  13. Macrophage activation syndrome in children with Kawasaki disease: diagnostic and therapeutic approaches · Seung Beom Han · 2020 · 48 citations · Cited by this paper
  14. Retrospective analysis of the clinical value of targeted nursing using a game-based model in children undergoing auricular reconstruction for congenital microtia · 2026 · Related
  15. Macrophage Activation Syndrome in Children: Update on Diagnosis and Treatment · Jin Lee · 2024 · 23 citations · Cited by this paper
  16. Clinical application value of metagenomic next-generation sequencing in children with fever of unknown origin · 2026 · Related
  17. Ruxolitinib targets JAK-STAT signaling to modulate neutrophil activation in refractory macrophage activation syndrome · Yuning Ma · 2025 · 23 citations · Cited by this paper
  18. Multimodal quantitative characterization and mechanistic exploration of paraspinal muscle groups in adolescent idiopathic scoliosis · 2026 · Related
  19. Efficacy of Anakinra on Multiple Coronary Arteries Aneurysms in an Infant with Recurrent Kawasaki Disease, Complicated by Macrophage Activation Syndrome · Grazia Bossi · 2022 · 17 citations · Cited by this paper
  20. Macrophage activation syndrome in pediatrics: 10 years data from an Indian center · Priyankar Pal · 2020 · 16 citations · Cited by this paper
  21. Immune editing shapes the cancer landscape · Shimona Starling · 2017 · 11 citations · Cited by this paper
  22. Efficacy and safety of ruxolitinib in adult patients with refractory rheumatic disease-associated macrophage activation syndrome · Jingjing Li · 2025 · 8 citations · Cited by this paper
  23. Macrophage activation syndrome in Kawasaki disease: a literature review of Korean studies · Dae Chul Jeong · 2025 · 7 citations · Cited by this paper
  24. Macrophage Activation Syndrome in Kawasaki Disease: Insights from a Systematic Literature Review on Diagnosis, Clinical Features, and Treatment · Giulia Inguscio · 2025 · 6 citations · Cited by this paper
  25. Hemophagocytic lymphohistiocytosis: do we have a solution for TMI (too much inflammation)? · Paul La Rosée · 2025 · 2 citations · Cited by this paper
  26. Breaking the storm: ruxolitinib as a lifeline in refractory hemophagocytic lymphohistiocytosis with macrophage activation syndrome · Tomás Escobar Gil · 2024 · 2 citations · Cited by this paper
  27. Accelerated response and reduced chemotherapy with ruxolitinib-based regimen therapy in pediatric hemophagocytic lymphohistiocytosis: a retrospective comparison with HLH-94 regimen · Na Song · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)